Keensight Capital acquired Symeres in 2021 Exemplify BioPharma provides integrated small molecule chemistry manufacturing and controls services to pharmaceutical and biotech partners Symeres is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback